Insights
Stage
All stages
Biotech has been the bright spot in a selective IPO market, and the reason is not indiscriminate risk appetite. Investors ...
California voted on whether to tax wealth and said no. Prop 40 failed [52 to 48], and Prop 42 wrote ...
Yesterday, I sat on the main stage at the One Way Summit in San Francisco with Immad Akhund of Mercury, ...
I have taken companies public in good windows and bad ones. The document you file in public is never the ...
Limited partners want cash, not marks. Private equity holds roughly 13,500 American companies, a third of them for more than ...
According to Q3 data from Crunchbase, roughly one third of all global VC capital went to just 27 companies raising ...
A year ago, we argued that SPACs had entered a fourth, more disciplined era: experienced sponsors, longer search periods, promotes ...
On Tuesday night, in the middle of San Francisco Tech Week, a full room of CFOs, founders, investors and bankers ...
Joe Baratta leaves Blackstone at year-end, and Blackstone will not replace him. Hernan Cristerna, JPMorgan's longtime M&A chief, retires the ...